The objective of these studies is to determine whether replication-deficient adenovirus vectors which carry the cDNA for angiogenic growth factors may provide a novel approach to induce angiogenesis and enhance collateral blood flow to ischemic tissues in clinically relevant animal models of myocardial and hindlimb ischemia/infarction. We have constructed adenovirus vectors which carry the cDNA for vascular endothelial growth factor (VEGF),for acidic fibroblast growth factor (aFGF) and for a recombinant, secreted form of aFGF. In vitro studies have shown that these vectors enhance endothelial cell proliferation and differentiation into capillary-like structures. In addition, when these vectors were resuspended in reconstituted basement membrane proteins (Matrigel) and the Matrigel was injected subcutaneously in mice, the viral vectors diffused out of the gel and induced angiogenesis in vivo. Subsequently, the therapeutic potential of the vectors coding for VEGF and for secreted aFGF was addressed in rabbit models of hindlimb ischemia and myocardial infarction, respectively. In one study severe hindlimb ischemia was induced by dissecting the femoral artery. Approximately 5 weeks after this surgical procedure autologous endothelial cells were infected ex vivo with the vector coding for VEGF and were injected in the iliac artery supplying the ischemic territory. The cells lodged in the capillaries of the ischemic hindlimb an produced VEGF which led to an improvement in collateral blood flow. In another study the adenovirus vector coding for secreted aFGF was injected along the proximal circumflex coronary artery. Approximately 2-3 weeks later the coronary artery was ligated near the site where the adenovirus vector had been injected and the area at risk for myocardial infarction was assessed with Monastral blue. The group injected with the vector coding for secreted aFGF exhibited a 50% decrease in the area at risk for myocardial infarction vs. both infected and uninfected controls.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Intramural Research (Z01)
Project #
1Z01AG000811-04
Application #
2565760
Study Section
Special Emphasis Panel (LCS)
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Institute on Aging
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Wei, Lei; Kanbe, Katsuaki; Lee, Mark et al. (2010) Stimulation of chondrocyte hypertrophy by chemokine stromal cell-derived factor 1 in the chondro-osseous junction during endochondral bone formation. Dev Biol 341:236-45
Ahmet, Ismail; Morrell, Chris; Lakatta, Edward G et al. (2009) Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor. J Pharmacol Exp Ther 331:178-85
Fedorova, Olga V; Zhuravin, Igor A; Agalakova, Natalia I et al. (2007) Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. J Hypertens 25:1834-44
Moon, Chanil; Krawczyk, Melissa; Paik, Doojin et al. (2006) Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties. J Pharmacol Exp Ther 316:999-1005
Moon, Chanil; Krawczyk, Melissa; Lakatta, Edward G et al. (2006) Therapeutic effectiveness of a single vs multiple doses of erythropoietin after experimental myocardial infarction in rats. Cardiovasc Drugs Ther 20:245-51
Ahmet, Ismayil; Lakatta, Edward G; Talan, Mark I (2005) Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy. Heart Fail Rev 10:289-96
Moon, Chanil; Krawczyk, Melissa; Paik, Doojin et al. (2005) Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window. Cardiovasc Drugs Ther 19:243-50
Ravi, Luke B; Poosala, Suresh; Ahn, Dongchoon et al. (2005) Red cell interactions with amyloid-beta(1-40) fibrils in a murine model. Neurobiol Dis 19:28-37
Ahmet, Ismayil; Wan, Ruiqian; Mattson, Mark P et al. (2005) Cardioprotection by intermittent fasting in rats. Circulation 112:3115-21
Fedorova, Olga V; Agalakova, Natalia I; Talan, Mark I et al. (2005) Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats. J Hypertens 23:1515-23

Showing the most recent 10 out of 18 publications